Antigen Information
General Information of This Antigen
| Antigen ID | TAR0EBTXG |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | B-lymphocyte antigen CD19 (CD19) |
|||||
| Gene Name | CD19 |
|||||
| Gene ID | ||||||
| Synonym | B-lymphocyte surface antigen B4; Differentiation antigen CD19;T-cell surface antigen Leu-12;CD_antigen=CD19 |
|||||
| Sequence |
MPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKP
FLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGE LFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSL NQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMW VMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKVSAVTLAYL IFCLCSLVGILHLQRALVLRRKRKRMTDPTRRFFKVTPPPGSGPQNQYGNVLSLPTPTSG LGRAQRWAAGLGGTAPSYGNPSSDVQADGALGSRSPPGVGPEEEEGEGYEEPDSEEDSEF YENDSNLGQDQLSQDGSGYENPEDEPLGPEDEDSFSNAESYENEDEELTQPVARTMDFLS PHGSAWDPSREATSLGSQSYEDMRGILYAAPQLRSIRGQPGPNHEEDADSYENMDNPDGP DPAWGGGGRMGTWSTR Click to Show/Hide
|
|||||
| Function |
Functions as coreceptor for the B-cell antigen receptor complex (BCR) on B-lymphocytes. Decreases the threshold for activation of downstream signaling pathways and for triggering B-cell responses to antigens. Activates signaling pathways that lead to the activation of phosphatidylinositol 3-kinase and the mobilization of intracellular Ca(2+) stores. Is not required for early steps during B cell differentiation in the blood marrow. Required for normal differentiation of B-1 cells. Required for normal B cell differentiation and proliferation in response to antigen challenges. Required for normal levels of serum immunoglobulins, and for production of high-affinity antibodies in response to antigen challenge.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
AFM-11
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AFM-11-2i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-2i linker |
[1] | |
AFM-11-4i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-4i linker |
[1] | |
AFM-11-3i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-11-3i linker |
[1] | |
AFM-11-6e |
Monomethyl auristatin E |
Microtubule (MT) |
AFM-11-6e linker |
[1] | |
AFM-11-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
AFM-11-amanitin linker |
[1] |
AFM-12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AFM-12-2i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-2i linker |
[1] | |
AFM-12-4i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-4i linker |
[1] | |
AFM-12-3i |
Monomethyl auristatin F |
Microtubule (MT) |
AFM-12-3i linker |
[1] | |
AFM-12-6e |
Monomethyl auristatin E |
Microtubule (MT) |
AFM-12-6e linker |
[1] | |
AFM-12-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
AFM-12-amanitin linker |
[1] |
Anti-CD19 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LCB73 |
PBD dimer |
Human deoxyribonucleic acid (hDNA) |
β-glucuronide trigger linker |
||
B43-genistein |
Genistein |
isoflavone tyrosine kinase |
Undisclosed |
Anti-CD19 IgG1 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ABBV-319 |
Glucocorticoid receptor modulator |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
Anti-CD19 mAb B4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
B4-SPP-DC44 |
DC44 |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[2] | |
B4-SMCC-DC4 |
Phosphate prodrugs 40 (DC4) |
Human Deoxyribonucleic acid (hDNA) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[2] | |
B4-SPP-DC4 |
Phosphate prodrugs 40 (DC4) |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[2] | |
B4-SPP-DC1 |
DC1 |
Human Deoxyribonucleic acid (hDNA) |
N-succinimidyl 4-(2-pyridyldithio) pentanoate (SPP) |
[2] |
Anti-CD19 mAb DI-B4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LCB14-0648 |
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0648 linker |
[1] | |
LCB14-0663 |
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0663 linker |
[1] | |
LCB14-0664 |
Monomethyl auristatin F |
Microtubule (MT) |
LCB14-0664 linker |
[1] | |
LCB14-6e |
Monomethyl auristatin E |
Microtubule (MT) |
LCB14-6e linker |
[1] | |
LCB14-alpha-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
LCB14-alpha-amanitin linker |
[1] | |
WO2017089895A1 ADC67 |
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089895A1_ADC67 linker |
[3] | |
WO2017089895A1 ADC68 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2017089895A1_ADC68 linker |
[3] | |
WO2017089895A1 ADC69 |
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089895A1_ADC69 linker |
[3] | |
WO2017089890A1 ADC67 |
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089890A1_ADC67 linker |
[4] | |
WO2017089890A1 ADC68 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2017089890A1_ADC68 linker |
[4] | |
WO2017089890A1 ADC69 |
Monomethyl auristatin F |
Microtubule (MT) |
WO2017089890A1_ADC69 linker |
[4] |
Anti-CD19 mAb hA19
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HA19-SN38 antibody-drug conjugate |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
[5] |
Anti-CD19 mAb hBU12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HBU12-mc-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[6] |
cHD37
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CHD37-2i |
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-2i linker |
[1] | |
CHD37-4i |
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-4i linker |
[1] | |
CHD37-3i |
Monomethyl auristatin F |
Microtubule (MT) |
cHD37-3i linker |
[1] | |
CHD37-6e |
Monomethyl auristatin E |
Microtubule (MT) |
cHD37-6e linker |
[1] | |
CHD37-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
cHD37-amanitin linker |
[1] |
Coltuximab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Coltuximab ravtansine |
DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
||
JP7623413B2 ExampleADC49 |
Undisclosed |
Undisclosed |
Undisclosed |
[7] | |
JP7560255B2 ControlADC49 |
Undisclosed |
Undisclosed |
Undisclosed |
[8] |
Denintuzumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Denintuzumab mafodotin |
MMAF |
Microtubule (MT) |
Maleimido-caproyl |
||
Denintuzumab-2i |
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-2i linker |
[1] | |
Denintuzumab-4i |
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-4i linker |
[1] | |
Denintuzumab-3i |
Monomethyl auristatin F |
Microtubule (MT) |
Denintuzumab-3i linker |
[1] | |
Denintuzumab-6e |
Monomethyl auristatin E |
Microtubule (MT) |
Denintuzumab-6e linker |
[1] | |
Denintuzumab-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Denintuzumab-amanitin linker |
[1] | |
hBU12-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[9] | |
hBU12-MC-vc-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[9] | |
hBU12-MC-vc-PABC-MMAF DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[9] | |
hBU12-1 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
[9] | |
hBU12-1 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
[9] | |
hBU12-2 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[9] | |
hBU12-2 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[9] | |
hBU12-3 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
[9] | |
hBU12-3 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
[9] | |
hBU12-4 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[9] | |
hBU12-4 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[9] | |
hBU12-5 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[9] | |
hBU12-5 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[9] | |
hBU12-6 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[9] | |
hBU12-6 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[9] | |
hBU12-7 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[9] | |
hBU12-7 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[9] | |
hBU12-8 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
[9] | |
hBU12-9 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
[9] | |
hBU12-10 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
[9] | |
hBU12-11 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[9] | |
hBU12-12 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[9] | |
hBU12-13 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[9] | |
hBU12-14 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
[9] | |
hBU12-15 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
[9] | |
hBU12-16 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
[9] | |
hBU12-17 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-18 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-19 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-20 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-21 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-22 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-23 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-24 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[9] | |
hBU12-25 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
[9] | |
hBU12-26 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
[9] | |
hBU12-27 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
[9] | |
hBU12-28 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
[9] | |
hBU12-29 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[9] | |
hBU12-30 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
[9] | |
hBU12-31 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
[9] | |
hBU12-32 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
[9] | |
hBU12-33 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
[9] | |
hBU12-34 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
[9] | |
hBU12-35 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
[9] | |
hBU12-36 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
[9] | |
hBU12-37 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
[9] | |
hBU12-38 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
[9] | |
hBU12-39 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
[9] | |
hBU12-1 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Dpr-MA |
[9] | |
hBU12-2 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[9] | |
hBU12-3 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Dpr-MA |
[9] | |
hBU12-4 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[9] | |
hBU12-5 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[9] | |
hBU12-6 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[9] | |
hBU12-7 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[9] | |
hBU12-8 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
[9] | |
hBU12-9 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
[9] | |
hBU12-10 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
[9] | |
hBU12-11 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[9] | |
hBU12-12 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[9] | |
hBU12-13 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[9] | |
hBU12-14 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
[9] | |
hBU12-15 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
[9] | |
hBU12-16 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
[9] | |
hBU12-17 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-18 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-19 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-20 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-21 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-22 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-23 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-24 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[9] | |
hBU12-25 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
[9] | |
hBU12-26 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
[9] | |
hBU12-27 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
[9] | |
hBU12-28 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
[9] | |
hBU12-29 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[9] | |
hBU12-30 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
[9] | |
hBU12-31 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
[9] | |
hBU12-32 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
[9] | |
hBU12-33 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
[9] | |
hBU12-34 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
[9] | |
hBU12-35 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
[9] | |
hBU12-36 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
[9] | |
hBU12-37 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
[9] | |
hBU12-38 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
[9] | |
hBU12-39 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
[9] | |
hBU12-MC-vc-PABC-MMAF DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[9] | |
hBU12-13 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[9] | |
hBU12-12 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[9] | |
hBU12-11 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[9] | |
hBU12-17 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[9] | |
hBU12-20 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[9] | |
hBU12-24 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[9] | |
hBU12-29 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[9] | |
JP7623413B2 ExampleADC50 |
Undisclosed |
Undisclosed |
Undisclosed |
[7] |
DI-B4-(LC)-GGGGGGG-CVIM
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Anti-CD19(LC)-G7VIM-2i |
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-2i linker |
[1] | |
Anti-CD19(LC)-G7VIM-4i |
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-4i linker |
[1] | |
Anti-CD19(LC)-G7VIM-3i |
Monomethyl auristatin F |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-3i linker |
[1] | |
Anti-CD19(LC)-G7VIM-6e |
Monomethyl auristatin E |
Microtubule (MT) |
Anti-CD19(LC)-G7VIM-6e linker |
[1] | |
Anti-CD19(LC)-G7VIM-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Anti-CD19(LC)-G7VIM-amanitin linker |
[1] |
GBR401
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
GBR401-2i |
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-2i linker |
[1] | |
GBR401-4i |
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-4i linker |
[1] | |
GBR401-3i |
Monomethyl auristatin F |
Microtubule (MT) |
GBR401-3i linker |
[1] | |
GBR401-6e |
Monomethyl auristatin E |
Microtubule (MT) |
GBR401-6e linker |
[1] | |
GBR401-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
GBR401-amanitin linker |
[1] |
hBU12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TW201803600A ADC-5 |
PBD |
Undisclosed |
Undisclosed |
[10] |
HBU12ec
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
SGN-CD19B |
SGD-1882 |
Human deoxyribonucleic acid (hDNA) |
Mc-Val-Ala |
Inebilizumab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Inebilizumab-2i |
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-2i linker |
[1] | |
Inebilizumab-4i |
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-4i linker |
[1] | |
Inebilizumab-3i |
Monomethyl auristatin F |
Microtubule (MT) |
Inebilizumab-3i linker |
[1] | |
Inebilizumab-6e |
Monomethyl auristatin E |
Microtubule (MT) |
Inebilizumab-6e linker |
[1] | |
Inebilizumab-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Inebilizumab-amanitin linker |
[1] |
Loncastuximab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Loncastuximab tesirine |
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
loncastuximab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IGAC-88 |
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
[11] |
MDX-1342
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MDX-1342-2i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-2i linker |
[1] | |
MDX-1342-4i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-4i linker |
[1] | |
MDX-1342-3i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1342-3i linker |
[1] | |
MDX-1342-6e |
Monomethyl auristatin E |
Microtubule (MT) |
MDX-1342-6e linker |
[1] | |
MDX-1342-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
MDX-1342-amanitin linker |
[1] |
MDX-1435
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
MDX-1435-2i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-2i linker |
[1] | |
MDX-1435-4i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-4i linker |
[1] | |
MDX-1435-3i |
Monomethyl auristatin F |
Microtubule (MT) |
MDX-1435-3i linker |
[1] | |
MDX-1435-6e |
Monomethyl auristatin E |
Microtubule (MT) |
MDX-1435-6e linker |
[1] | |
MDX-1435-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
MDX-1435-amanitin linker |
[1] |
Mouse CD19 antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
37788373 ADC1 |
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-1 |
[12] | |
37788373 ADC2 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-1 |
[12] | |
37788373 ADC3 |
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
[12] | |
37788373 ADC4 |
(R)-Budesonide |
Undisclosed |
Mc-Val-Glu-RG-1 |
[12] | |
37788373 ADC5 |
(R)-Budesonide |
Undisclosed |
MC-Ser-Cit-RG-1 |
[12] | |
37788373 ADC6 |
(R)-Budesonide |
Undisclosed |
MP-Ala-Ala-RG-1 |
[12] | |
37788373 ADC7 |
(R)-Budesonide |
Undisclosed |
MP-Asn-Cit-RG-1 |
[12] | |
37788373 ADC8 |
(R)-Budesonide |
Undisclosed |
MP-Gln-Cit-RG-1 |
[12] | |
37788373 ADC9 |
Triamcinolone acetonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
[12] | |
37788373 ADC10 |
(S)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-1 |
[12] | |
37788373 ADC11 |
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-2 |
[12] | |
37788373 ADC12 |
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-4 |
[12] | |
37788373 ADC13 |
(R)-Budesonide |
Undisclosed |
MC-Ala-Ala-RG-6 |
[12] | |
37788373 ADC14 |
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-7 |
[12] | |
37788373 ADC15 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-8 |
[12] | |
37788373 ADC16 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-9 |
[12] | |
37788373 ADC17 |
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-10 |
[12] | |
37788373 ADC18 |
(R)-Budesonide |
Undisclosed |
MC-Val-Cit-RG-11 |
[12] | |
37788373 ADC19 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-12 |
[12] | |
37788373 ADC20 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-13 |
[12] | |
37788373 ADC21 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-14 |
[12] | |
37788373 ADC22 |
(R)-Budesonide |
Undisclosed |
MC-Val-Ala-RG-15 |
[12] | |
37788373 ADC23 |
(R)-Budesonide |
Undisclosed |
MP-Ala-Ala-RG-9 |
[12] |
Obexelimab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Obexelimab-2i |
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-2i linker |
[1] | |
Obexelimab-4i |
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-4i linker |
[1] | |
Obexelimab-3i |
Monomethyl auristatin F |
Microtubule (MT) |
Obexelimab-3i linker |
[1] | |
Obexelimab-6e |
Monomethyl auristatin E |
Microtubule (MT) |
Obexelimab-6e linker |
[1] | |
Obexelimab-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Obexelimab-amanitin linker |
[1] |
RC58
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
RC58-ADC-1 |
Dumycin-7 |
Human Deoxyribonucleic acid (hDNA) |
Bis-bromine linker-PEG4-Asn-Ala-ethylenediamine |
[13] | |
RC58-ADC-3 |
Duostain 3 |
Undisclosed |
Bis-bromine linker-mono-glycine-PEG12-PAB |
[13] | |
RC58-ADC-2 |
Duostain 3 |
Undisclosed |
Bis-bromine linker-PEG2-VC-PAB |
[13] |
Tafasitamab
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Tafasitamab-2i |
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-2i linker |
[1] | |
Tafasitamab-4i |
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-4i linker |
[1] | |
Tafasitamab-3i |
Monomethyl auristatin F |
Microtubule (MT) |
Tafasitamab-3i linker |
[1] | |
Tafasitamab-6e |
Monomethyl auristatin E |
Microtubule (MT) |
Tafasitamab-6e linker |
[1] | |
Tafasitamab-amanitin |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Tafasitamab-amanitin linker |
[1] |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
LCB-73 |
Undisclosed |
Undisclosed |
Undisclosed |
[14] | |
NI-2201 |
Undisclosed |
Undisclosed |
Undisclosed |
[15] | |
TE-1522 |
Undisclosed |
Undisclosed |
Undisclosed |
[16] | |
HuB4-DGN462 |
DGN462 |
Human Deoxyribonucleic acid (hDNA) |
Sulfo-SPDB |
[17] | |
Anti-B4 monoclonal antibody-DC1 conjugate |
DC1 |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
[18] | |
NV102 |
Doxorubicin |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
[19] | |
CD19-ATAC |
HDP 30.2115 |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Mal-Val-Ala-PAB |
[20] | |
Anti-CD19 monoclonal antibody-liposomal sodium butyrate conjugate |
Sodium butyrate |
Histone deacetylase 1 (HDAC1) |
Undisclosed |
[21] | |
CO-1008 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
B cell High Density Microparticles |
Undisclosed |
Undisclosed |
Undisclosed |
[23] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CD19 mAb-TP |
Triptolide |
Nuclear factor NF-kappa-B p105 subunit (NFKB1) |
PEG2000-NHS |
[24] | |
CN119365219A+ADC |
Undisclosed |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[25] |
References
